Breakout Ventures

Breakout Ventures invests in early-stage companies building bio-based solutions to improve human health and sustainability. They support companies from seed to scale, providing resources and a network to help them reach critical milestones. Their focus is on creative bioscience entrepreneurs building the future.

Offices: San Francisco (United States)

Investment Stages: Seed, Series A, Series B

Markets: Biotechnology, Life Sciences, Therapeutics, Biomanufacturing, Sustainable Materials

Founded Year: 2016

Investor Type: Venture Capital

Portfolio Companies: Cytovale, Immusoft, Noetik, Twelve, Ecovative Design, A-ALPHA BIO, Appia Bio, Canaery, CellChorus, Checkerspot, Copernic Catalysts, EnPlusOne Bio, Incendia Therapeutics, Modern Meadow, Parallel Bio, Passkey Therapeutics, Phantom Neuro, Shiratronics, Strm.Bio, Surf Bio, TFC Therapeutics, Vitra Labs, ZymoChem

Website: https://www.breakout.vc

Team Page: https://www.breakout.vc/team/

Portfolio Link: https://www.breakout.vc/portfolio/

LinkedIn: https://www.linkedin.com/company/breakout-ventures/

Twitter: https://twitter.com/breakout_vc

Instagram:

Crunchbase: https://www.crunchbase.com/organization/breakoutventures

Pitchbook: